Pregnancy outcomes from the global pharmacovigilance database on interferon beta-1b exposure
K Hellwig, F Duarte Caron… - Therapeutic …, 2020 - journals.sagepub.com
Background: The goal of the present cohort study was to review outcomes of patients
exposed to interferon beta-1b during pregnancy. Methods: Pregnancy cases with exposure …
exposed to interferon beta-1b during pregnancy. Methods: Pregnancy cases with exposure …
Pregnancy outcomes in patients exposed to interferon beta-1b
RS Romero, C Lünzmann, JP Bugge - Journal of Neurology …, 2015 - jnnp.bmj.com
Methods The objective of the present analysis was to review pregnancy outcomes in
patients who were exposed to interferon beta-1b (Betaferon/Betaseron; Bayer HealthCare …
patients who were exposed to interferon beta-1b (Betaferon/Betaseron; Bayer HealthCare …
Inform Interferon Beta Exposure in the 2nd and 3rd Trimester of Pregnancy: A register-based drug utilisation study in Finland and Sweden
MS Espin, K Suzart-Woischnik, N Grimes… - Multiple Sclerosis …, 2022 - msard-journal.com
Background: Previous studies showed no increased risk of interferon beta use before or
early in pregnancy among women with multiple sclerosis (MS). However, knowledge about …
early in pregnancy among women with multiple sclerosis (MS). However, knowledge about …
Pregnancy outcomes after exposure to interferon beta: a register-based cohort study among women with MS in Finland and Sweden
KM Hakkarainen, R Juuti, S Burkill… - Therapeutic …, 2020 - journals.sagepub.com
Background Our aim was to estimate and compare the prevalence of adverse pregnancy
outcomes among pregnant women with multiple sclerosis (MS) exposed to interferon beta …
outcomes among pregnant women with multiple sclerosis (MS) exposed to interferon beta …
Final results from the Betaseron (interferon β-1b) Pregnancy Registry: a prospective observational study of birth defects and pregnancy-related adverse events
PK Coyle, SM Sinclair, AE Scheuerle, JM Thorp… - BMJ open, 2014 - bmjopen.bmj.com
Objective Women with multiple sclerosis are often diagnosed and treated during their
reproductive years. Limited data are available on the safety of treatment during pregnancy …
reproductive years. Limited data are available on the safety of treatment during pregnancy …
Final Results from the AVONEX®(Intramuscular Interferon Beta-1a) Pregnancy Exposure Registry (P06. 191)
S Richman, K Wallace, S Liu, B Sperling - 2012 - AAN Enterprises
Objective: To prospectively record and analyze pregnancy outcomes in women with multiple
sclerosis (MS) who were exposed to intramuscular interferon beta-1a (IM IFNβ-1a) within …
sclerosis (MS) who were exposed to intramuscular interferon beta-1a (IM IFNβ-1a) within …
Pregnancy and infant outcomes with interferon beta: data from the European Interferon Beta Pregnancy Registry and population based registries in Finland and …
K Hellwig, Y Geissbuehler, M Sabidó… - … sclerosis and related …, 2018 - msard-journal.com
Background: Women with multiple sclerosis (MS) are often diagnosed/treated at
childbearing age. Until recently, data on MS and interferon beta (IFNβ) exposure during …
childbearing age. Until recently, data on MS and interferon beta (IFNβ) exposure during …
Analysis of Pregnancy Outcomes Following Exposure to Intramuscular Interferon Beta-1a: The AVONEX® Pregnancy Exposure Registry
B Weinstock-Guttman, AP Ross, J Planton… - Drugs-Real World …, 2023 - Springer
Abstract Background and Objectives There is a lack of well-controlled US studies of
intramuscular (IM) interferon beta (IFNβ)-1a use in pregnant women with multiple sclerosis; …
intramuscular (IM) interferon beta (IFNβ)-1a use in pregnant women with multiple sclerosis; …
[HTML][HTML] Impact of interferon beta exposure on birth outcome and child development–results from the post-authorisation safety study PRIMA
J Klehmet, Y Begus-Nahrmann, K Taipale… - Multiple Sclerosis and …, 2023 - Elsevier
Background Interferon beta therapies are well-established disease-modifying treatments for
patients with relapsing multiple sclerosis (MS). Based on clinical evidence from two large …
patients with relapsing multiple sclerosis (MS). Based on clinical evidence from two large …
The reproductive effects of beta interferon therapy in pregnancy: a longitudinal cohort
Objective: To determine whether interferon therapy during human pregnancy increases
reproductive risks in women. Methods: This longitudinal, controlled cohort study consisted of …
reproductive risks in women. Methods: This longitudinal, controlled cohort study consisted of …